Accumed Research Associates

Garden City, New York 11530-1664

3 studies enrolling now · 73 studies all time

What they study most

Albuminuria, Benign Prostatic Hyperplasia, Bladder Cancer, Bladder Neoplasm, Bladder Pain Syndrome, Carcinoma in Situ, Chronic Kidney Diseases, Diabetes, Erectile Dysfunction, Hypertension, Hypogonadal Males, Hypogonadism

Studies at this site

• Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
• Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer — Recruiting now
• Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria — Recruiting now
• Optilume™ BPH Catheter System in Men With Symptomatic BPH — Running, not enrolling
• A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Running, not enrolling
• Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence — Running, not enrolling
• Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome — Completed
• A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer — Running, not enrolling
• Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men — Starting soon
• A New Sildenafil Oral Film in Patients With Erectile Dysfunction — Completed
• A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months — Running, not enrolling
• Study of V117957 in Overactive Bladder Syndrome — Completed
• A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome — Stopped early
• Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia — Completed
• Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men — Completed
• A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Stopped early
• Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence — Withdrawn before enrolling
• PK and Safety of SI-722 in IC/BPS — Completed
• Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence — Withdrawn before enrolling
• Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men — Completed
• Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia) — Completed
• Evaluation of the Accuracy and Usability of the ACR | U.S. Urine Analysis Test System in the Lay User Hands — Completed
• Evaluation of the Accuracy and Usability of the Minuteful - Kidney Urine Analysis Test System in the Lay User Hands — Completed
• A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants — Completed
• A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel — Status unconfirmed
• PSD502 in Subjects With Premature Ejaculation — Completed
• Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) — Stopped early
• BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence — Completed
• Prospective US Radiofrequency SUI Trial — Status unconfirmed
• Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer — Completed
• Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men — Completed
• Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) — Completed
• Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence — Completed
• An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). — Completed
• A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) — Completed
• A Clinical Trial of KT07 Capsule in the U.S.A — Completed
• A Comparative, Controlled Study to Evaluate the Lay User Accuracy and Performance of the Dip Home-Based Dipstick Analyzer — Completed
• ACR | LAB Urine Analysis Test System Evaluation of Performance — Completed
• Dip Home-Based Dipstick Analyzer Performance Evaluation — Completed
• IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE) — Completed
• Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer — Completed
• Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer — Completed
• Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer — Completed
• Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer — Completed
• Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer — Stopped early
• Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US — Completed
• Efficacy, Pharmacokinetics and Safety of Testosterone — Completed
• A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator — Completed
• The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy — Completed
• Healthy.io Method Comparison & User Performance Study — Completed